title: Abnormal in vitro proliferation of splenic mononuclear phagocytes from autoimmune motheaten mice.
abstract: Motheaten mice develop combined immunodeficiency and fatal autoimmune disease that follow autosomal recessive inheritance. In splenocyte cultures of motheaten mice, supplemented with 5% normal serum proliferating cells (MP) were present exhibiting morphologic characteristics of mononuclear phagocytes at light and electron microscopic levels. The macrophage nature of these cells was confirmed by the lack of Thy-1 antigen and immunoglobulins; the expression of Mac-1 antigen, FcR for IgG, and Ia antigens on their cell surfaces; their ability to phagocytize EA and adhere to plastic; the presence of nonspecific esterase and lysomal enzymes in their cytoplasm; and the pattern of peroxidase localization similar to monocyte-derived macrophages. MP from motheaten mice exponentially grew in culture in the absence of exogenous growth factors with a doubling time of approximately 76 hr. Although these cells were present in splenocyte cultures of normal controls, their number did not increase during the culture period under the same conditions. The addition of dextran sulfate further enhanced the proliferation of MP from motheaten mice, and induced exponential growth of these cells from normal controls, reaching only the level of unstimulated cells from motheaten mice. Radioautographic analysis demonstrated that MP substantially contributed to the elevated spontaneous and dextran sulfate-induced DNA synthesis in splenocyte cultures. Therefore, the in vitro abnormality of MP may be indicative of in vivo aberrancies of macrophages from motheaten mice and lends credence for investigating the role of macrophages in immunodeficiency and autoimmunity that develop very early in motheaten mice.
mesh_terms: D000818:Animals; D001327:Autoimmune Diseases / Q000235:genetics / Q000276:immunology*; D002455:Cell Division / Q000187:drug effects; D004247:DNA / Q000096:biosynthesis; D016264:Dextran Sulfate; D003911:Dextrans / Q000494:pharmacology; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000235:genetics / Q000276:immunology*; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000166:cytology / Q000276:immunology / Q000648:ultrastructure; D008264:Macrophages / Q000166:cytology / Q000276:immunology / Q000648:ultrastructure; D051379:Mice; D008817:Mice, Mutant Strains / Q000276:immunology*; D010586:Phagocytes / Q000166:cytology* / Q000648:ultrastructure; D010641:Phenotype; D013154:Spleen / Q000166:cytology; D013936:Thymidine / Q000378:metabolism
chemical_list: D003911:Dextrans; D004247:DNA; D016264:Dextran Sulfate; D013936:Thymidine